Hypertension Pharmacogenomics in CKD: The Clinical Relevance and Public Health Implications.
Publication
, Journal Article
Geng, T-T; Jafar, TH
Published in: Kidney360
February 2022
Duke Scholars
Published In
Kidney360
DOI
EISSN
2641-7650
ISSN
2641-7650
Publication Date
February 2022
Volume
3
Issue
2
Start / End Page
204 / 207
Related Subject Headings
- Renal Insufficiency, Chronic
- Public Health
- Pharmacogenetics
- Medical History Taking
- Hypertension
- Humans
- 4202 Epidemiology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Geng, T.-T., & Jafar, T. H. (2022). Hypertension Pharmacogenomics in CKD: The Clinical Relevance and Public Health Implications. Kidney360, 3(2), 204–207. https://doi.org/10.34067/kid.0007792021
Geng, Ting-Ting, and Tazeen H. Jafar. “Hypertension Pharmacogenomics in CKD: The Clinical Relevance and Public Health Implications.” Kidney360 3, no. 2 (February 2022): 204–7. https://doi.org/10.34067/kid.0007792021.
Geng T-T, Jafar TH. Hypertension Pharmacogenomics in CKD: The Clinical Relevance and Public Health Implications. Kidney360. 2022 Feb;3(2):204–7.
Geng, Ting-Ting, and Tazeen H. Jafar. “Hypertension Pharmacogenomics in CKD: The Clinical Relevance and Public Health Implications.” Kidney360, vol. 3, no. 2, Feb. 2022, pp. 204–07. Epmc, doi:10.34067/kid.0007792021.
Geng T-T, Jafar TH. Hypertension Pharmacogenomics in CKD: The Clinical Relevance and Public Health Implications. Kidney360. 2022 Feb;3(2):204–207.
Published In
Kidney360
DOI
EISSN
2641-7650
ISSN
2641-7650
Publication Date
February 2022
Volume
3
Issue
2
Start / End Page
204 / 207
Related Subject Headings
- Renal Insufficiency, Chronic
- Public Health
- Pharmacogenetics
- Medical History Taking
- Hypertension
- Humans
- 4202 Epidemiology
- 3202 Clinical sciences